Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-04-01 Purchase | 2025-04-03 6:05 pm | ALUMIS INC. | ALMS | Babler Martin President, CEO and Chairman | 15,650 | $6.4366 | $100,733 | 106,454 (Indirect) | View |
| 2024-07-01 Sale | 2024-07-01 4:35 pm | ALUMIS INC. | ALMS | Babler Martin President, CEO and Chairman | 90,804 | $0 | $0 | 2,491,762 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-07-29 Option Award | 2025-07-31 9:05 pm | N/A 2035-07-28 | ALUMIS INC. | ALMS | Babler Martin President, CEO and Chairman | 812,000 | $0 | 921,454 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-13 4:13 pm | N/A 2035-06-11 | Prelude Therapeutics Inc | PRLD | Babler Martin Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2025-02-18 Option Award | 2025-02-20 6:30 pm | N/A 2035-02-17 | ALUMIS INC. | ALMS | Babler Martin President, CEO and Chairman | 523,000 | $0 | 523,000 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-05 4:01 pm | N/A 2035-02-03 | 89bio Inc. | ETNB | Babler Martin Director | 56,400 | $0 | 56,400 (Direct) | View |
| 2024-06-27 Option Award | 2024-07-01 4:35 pm | N/A 2034-06-26 | ALUMIS INC. | ALMS | Babler Martin President, CEO and Chairman | 2,491,762 | $0 | 2,491,762 (Direct) | View |
Ownership | 2024-06-27 4:02 pm | N/A N/A | ALUMIS INC. | ALMS | Babler Martin President, CEO and Chairman | 0 | $0 | 2,448,982 (Indirect) | View |
| 2024-06-14 Option Award | 2024-06-18 4:11 pm | N/A 2034-06-13 | Prelude Therapeutics Inc | PRLD | Babler Martin Director | 23,500 | $0 | 23,500 (Direct) | View |
| 2024-05-02 Option Award | 2024-05-03 4:01 pm | N/A 2034-05-02 | 89bio Inc. | ETNB | Babler Martin Director | 67,700 | $0 | 67,700 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:11 pm | N/A 2033-06-15 | Prelude Therapeutics Inc | PRLD | Babler Martin Director | 23,500 | $0 | 23,500 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 4:24 pm | N/A 2033-06-07 | Neoleukin Therapeutics Inc. | NLTX | Babler Martin Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:13 pm | N/A 2032-06-16 | Prelude Therapeutics Inc | PRLD | Babler Martin Director | 31,293 | $0 | 31,293 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-16 6:22 pm | N/A 2032-05-11 | Neoleukin Therapeutics Inc. | NLTX | Babler Martin Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-07-19 Option Award | 2021-07-20 8:30 pm | N/A 2031-07-18 | Prelude Therapeutics Inc | PRLD | Babler Martin Director | 36,400 | $0 | 36,400 (Direct) | View |
| 2021-05-11 Option Award | 2021-05-13 5:36 pm | N/A 2031-05-10 | Neoleukin Therapeutics Inc. | NLTX | Babler Martin Director | 25,000 | $0 | 25,000 (Direct) | View |
Ownership | 2021-01-06 9:39 pm | N/A N/A | Omega Alpha SPAC | OMEG | Babler Martin Director | 0 | $0 | 35,000 (Direct) | View |